Sorrento tanks on bankruptcy filing

Sorrento Therapeutics

13/02/2023 12:32

** Shares of biopharma firm Sorrento Therapeutics  SRNE.O 
tank 35% to 61 cents in premarket trade
    ** Co and its non-opioid painkiller development unit
Scintilla Pharmaceuticals commence Chapter 11 proceedings under
the U.S. bankruptcy code
    ** SRNE says it will continue business operations in
accordance with bankruptcy code
    ** Up to last close, stock up 6.1% YTD
 (Reporting by Nandhini Srinivasan in Bengaluru)
 ((nandhini.srinivasan@thomsonreuters.com))